RNTXRein Therapeutics, Inc.同业对比
Rein Therapeutics, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RNTX本股 | $61M#9 | — | 1.1x#7 | — | — | 20.7%#5 | — | -90.4%#9 | — | — | -38.7%#8 | — |
| PLRX | $67M#2 | — | 0.5x#1 | — | — | -29.0%#10 | — | 101.6%#1 | — | — | -28.5%#7 | — |
| XBIT | $66M#3 | — | 0.5x#2 | — | -100.0%#7 | -18.2%#9 | — | -35.5%#4 | — | — | — | — |
| SPRO | $66M#4 | 8.0x#3 | 1.5x#8 | 5.2x#4 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 19.4%#2 | — | — | — | — |
| BOLD | $64M#5 | — | 1.0x#6 | — | — | 11.0%#6 | — | -88.2%#8 | — | — | 148.7%#1 | — |
| EVFM | $63M#6 | — | — | 3.1x#3 | 4.2%#5 | 104.4%#2 | 16.7%#2 | — | — | — | — | — |
| TLPH | $62M#7 | — | 4.3x#10 | 2206.0x#9 | — | -9.9%#8 | -48157.1%#9 | -99.2%#10 | — | — | 21.4%#3 | — |
| SKYE | $61M#8 | — | — | — | — | -110.5%#15 | — | — | — | — | — | — |
| HRTX | $60M#10 | — | 8.7x#12 | 0.4x#1 | 7.4%#4 | -42.9%#11 | -1.6%#3 | -289.5%#12 | — | — | -74.2%#11 | — |
| IBIO | $77M#1 | — | 0.9x#5 | 765.3x#7 | -75.0%#6 | -78.7%#14 | -35141.0%#8 | -38.3%#5 | — | — | 37.3%#2 | — |
| DWTX | $59M#11 | 0.9x#2 | 0.9x#4 | — | — | -177.4%#16 | — | -50.1%#7 | — | — | -65.2%#10 | — |
| IBO | $58M#12 | 0.6x#1 | 5.3x#11 | 1797.2x#8 | — | 52.1%#3 | -13381.3%#6 | -110.0%#11 | -18.9%#1 | — | -22.7%#6 | — |
| SER | $57M#13 | — | — | 436.7x#6 | 132.1%#3 | -72.2%#13 | -18478.5%#7 | — | — | 5#1 | -56.2%#9 | — |
| NMAD | $56M#14 | — | 2.4x#9 | 281.0x#5 | — | -69.5%#12 | -2553.8%#5 | -25.4%#3 | — | — | — | — |
| PDSB | $55M#15 | — | — | — | — | 8.3%#7 | — | — | -541.6%#2 | — | -16.5%#5 | — |
| XLO | $52M#16 | — | 0.7x#3 | 1.2x#2 | 589.9%#2 | 39.8%#4 | -95.9%#4 | -48.5%#6 | — | — | -15.4%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议